Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-16 Purchase |
2024-09-18 11:40 am |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
20,000 | $0.04 | $800 | 4,606,626 (Direct) |
View |
| 2024-02-26 Purchase |
2024-02-29 6:11 pm |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Co-President & COO |
115,200 | $0.12755 | $14,694 | 795,718 (Indirect Direct) |
View |
| 2023-08-25 Purchase(A) |
2024-01-03 4:59 pm |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
121,000 | $0.12632 | $15,285 | 680,518 (Indirect Direct) |
View |
| 2023-12-20 Sale |
2023-12-21 11:34 am |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
32,500 | $0.05 | $1,625 | 4,586,626 (Direct) |
View |
| 2022-10-09 Purchase |
2023-12-19 7:44 pm |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
139,200 | $0.2221 | $30,916 | 9,066,552 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 7:44 pm |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
6,000 | $0.11 | $660 | 9,066,552 (Direct) |
View |
| 2023-08-25 Purchase |
2023-12-04 8:33 pm |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
15,609 | $0.1296 | $2,023 | 680,518 (Indirect Direct) |
View |
| 2022-09-20 Purchase |
2023-06-02 1:23 pm |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
29,450 | $0.28975 | $8,533 | 559,518 (Indirect Direct) |
View |
| 2022-11-03 Purchase |
2022-12-01 1:35 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
52,600 | $0.40352 | $21,225 | 12,196,651 (Indirect Direct) |
View |
| 2022-10-31 Purchase |
2022-11-03 2:50 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
27,500 | $0.43545 | $11,975 | 12,144,051 (Indirect Direct) |
View |
| 2022-10-24 Purchase |
2022-10-31 2:59 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
69,400 | $0.27793 | $19,288 | 12,116,551 (Indirect Direct) |
View |
| 2022-10-19 Purchase |
2022-10-24 6:34 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
65,000 | $0.17385 | $11,300 | 12,047,151 (Indirect Direct) |
View |
| 2022-10-17 Purchase |
2022-10-19 2:21 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
45,000 | $0.19333 | $8,700 | 11,982,151 (Indirect Direct) |
View |
| 2022-10-13 Purchase |
2022-10-17 1:01 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
97,500 | $0.17641 | $17,200 | 11,937,151 (Indirect Direct) |
View |
| 2022-10-11 Purchase |
2022-10-13 4:05 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
165,000 | $0.0803 | $13,250 | 11,839,651 (Indirect Direct) |
View |
| 2022-09-26 Purchase |
2022-10-12 1:04 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
185,000 | $0.11011 | $20,370 | 11,674,651 (Indirect Direct) |
View |
| 2022-07-19 Purchase |
2022-07-25 12:49 pm |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
3,200 | $0.39 | $1,248 | 530,068 (Indirect Direct) |
View |
| 2022-05-27 Purchase |
2022-06-03 11:52 am |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Director & COO |
5,000 | $0.385 | $1,925 | 526,868 (Indirect Direct) |
View |
| 2022-05-20 Purchase |
2022-06-02 7:49 pm |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
7,000 | $0.49286 | $3,450 | 11,489,651 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Option Award |
2024-02-05 4:40 pm |
N/A 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director |
100,000 | $0.15 | 100,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:39 pm |
N/A 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director |
100,000 | $0.15 | 100,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:38 pm |
N/A 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
100,000 | $0.15 | 100,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:37 pm |
2024-02-01 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | Stark Charles William CSO & EVP Clinical Development |
200,000 | $0.15 | 200,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:35 pm |
2024-02-01 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | Sekulich George Co-President & CCO |
200,000 | $0.15 | 200,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:34 pm |
2024-02-01 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | NAGASAKI YASUSHI CFO |
200,000 | $0.15 | 200,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:32 pm |
2024-02-01 2034-01-31 |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Co-President & COO |
200,000 | $0.15 | 200,000 (Direct) |
View |
Ownership(A) |
2023-12-20 10:33 am |
N/A N/A |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
0 | $0 | 278,500 (Direct) |
View |
| 2023-12-15 Other |
2023-12-19 7:44 pm |
N/A N/A |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
240,000 | $0 | 9,066,552 (Direct) |
View |
| 2023-12-15 Other |
2023-12-19 7:44 pm |
N/A N/A |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
4,447,426 | $0.29 | 9,066,552 (Direct) |
View |
| 2023-01-18 Other |
2023-12-19 7:40 pm |
N/A N/A |
Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director |
2,000,000 | $0.5 | 9,800,014 (Direct) |
View |
| 2023-12-15 Other |
2023-12-19 7:40 pm |
N/A N/A |
Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director |
3,760,983 | $0.29 | 9,800,014 (Direct) |
View |
| 2023-01-12 Option Award(A) |
2023-01-19 5:54 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
500,000 | $4.5 | 500,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:36 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director |
100,000 | $4.5 | 100,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:35 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director |
100,000 | $4.5 | 100,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:34 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
100,000 | $4.5 | 100,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:32 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | Stark Charles William SVP, Clinical Development |
100,000 | $4.5 | 100,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:31 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | Sekulich George CIO & SVP |
100,000 | $4.5 | 100,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:29 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | NAGASAKI YASUSHI CFO |
150,000 | $4.5 | 150,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 2:27 pm |
N/A 2033-01-11 |
Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO |
750,000 | $4.5 | 750,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 1:59 pm |
2023-01-12 2028-01-11 |
Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner |
7,500,000 | $4.5 | 0 (Direct) |
View |
Ownership |
2022-10-06 1:05 pm |
2016-01-14 2026-01-14 |
Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director |
0 | $0 | 220,529 (Direct) |
View |
Ownership |
2022-10-06 1:03 pm |
2022-09-16 2025-09-16 |
Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director |
0 | $0 | 240,000 (Direct) |
View |